MedTech Industry Dynamics
MedTech Industry Dynamics
MintNeuro has raised $5 million to accelerate commercial scale-up of its specialized semiconductor chips for neural devices and brain-computer interfaces, with funding from European and U.S. investors to drive product launch, partner adoption, and international expansion.
Read MoreCambridge Heartwear has secured a £184 million NHS tender for HeartSense, a medical-grade, wirelessly charged, reusable ECG wearable that combines multi-channel ECG monitoring, adaptive AI, and wireless charging to enable cardiac diagnostics in primary and community care settings.
Read MoreThe UK government has launched the Dementia Challenge, backed by up to £80 million, to accelerate adoption of innovative diagnostic technologies in the NHS, with the goal of diagnosing 92% of people within 18 weeks of referral compared with around 60% today.
Read MoreC2N Diagnostics has partnered with Cambridge Cognition and The Alzheimer’s Trust on World Alzheimer’s Day to create an integrated, scalable diagnostic pathway in the UK, combining the PrecivityAD2 blood test, CANTAB Pathway digital cognitive assessments, and national phlebotomy and MRI infrastructure.
Read MoreEDX Medical plans to launch its BC95 bowel cancer testing service in the UK, combining blood, faecal, and genetic analysis to support earlier detection and hereditary risk assessment.
Read MoreBot Image’s ProstatID AI software has received UKCA certification under EU MDR 2017/745, clearing the way for expanded clinical use across the UK and other international markets.
Read MoreSubtle Medical has received EU MDR CE marking and entered the UK market with its AI-driven MRI enhancement software SubtleHD, aimed at improving image quality, scan speed, and operational efficiency.
Read MoreNew Commission will advise the MHRA on AI regulation, aiming to accelerate safe NHS adoption of next-generation digital health technologies.
Read MoreMedtronic doubles London office and workforce, establishing its largest global centre for AI and digital surgical technologies.
Read MoreBelfast-based Neurovalens secures £6m to expand U.S. and global sales of its FDA-cleared non-invasive neurotechnology devices.
Read More
